167 related articles for article (PubMed ID: 9622058)
21. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
22. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.
Schlesinger C; Kamoi S; Ascher SM; Kendell M; Lage JM; Silverberg SG
Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130
[TBL] [Abstract][Full Text] [Related]
23. Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure.
Fles R; Hoogendoorn WE; Platteel I; Scheerman CE; de Leeuw-Mantel G; Mourits MJ; Hollema H; van Leeuwen FE; van Boven HH; Nederlof PM
Genes Chromosomes Cancer; 2010 Aug; 49(8):699-710. PubMed ID: 20544844
[TBL] [Abstract][Full Text] [Related]
24. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.
Kennedy MM; Baigrie CF; Manek S
Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen-associated polyps (basalomas) arising in multiple endometriotic foci: A case report and review of the literature.
Schlesinger C; Silverberg SG
Gynecol Oncol; 1999 May; 73(2):305-11. PubMed ID: 10329051
[TBL] [Abstract][Full Text] [Related]
26. [Tamoxifen and giant endometrial polyps].
Caschetto S; Cassaro N; Consalvo P; Caragliano L
Minerva Ginecol; 2000 Nov; 52(11):459-63. PubMed ID: 11256174
[TBL] [Abstract][Full Text] [Related]
27. Endometrial cancer and tamoxifen.
Burke C
Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168
[No Abstract] [Full Text] [Related]
28. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
29. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
[TBL] [Abstract][Full Text] [Related]
30. [Benign endometrial lesions induced by tamoxifen].
De Muylder X
J Gynecol Obstet Biol Reprod (Paris); 1999 Sep; 28(5):420-4. PubMed ID: 10566160
[TBL] [Abstract][Full Text] [Related]
31. The endometrium in breast cancer patients on tamoxifen.
Dallenbach-Hellweg G; Schmidt D; Hellberg P; Bourne T; Kreuzwieser E; Dören M; Rydh W; Rudenstam G; Granberg S
Arch Gynecol Obstet; 2000 Apr; 263(4):170-7. PubMed ID: 10834325
[TBL] [Abstract][Full Text] [Related]
32. [Role of steroid hormones and related biological substances in the etiology of endometrial carcinomas].
Lang-Avérous G; Rupp K; Wehner H; Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():366-9. PubMed ID: 1724843
[TBL] [Abstract][Full Text] [Related]
33. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
Schmidt D; Horn LC
Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
[TBL] [Abstract][Full Text] [Related]
34. Amplification and expression of the HMGIC gene in a benign endometrial polyp.
Dal Cin P; Wanschura S; Kazmierczak B; Tallini G; Dei Tos A; Bullerdiek J; Van den Berghe I; Moerman P; Van den Berghe H
Genes Chromosomes Cancer; 1998 Jun; 22(2):95-9. PubMed ID: 9598795
[TBL] [Abstract][Full Text] [Related]
35. [Endometrial evaluation prior to tamoxifen: preliminary results of a prospective study].
Berlière M; Galant C; Gillerot S; Charles A; Donnez J
Bull Cancer; 1998 Aug; 85(8):721-4. PubMed ID: 9754081
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium.
Farrell R; Scurry J; Otton G; Hacker NF
Gynecol Oncol; 2005 Aug; 98(2):254-62. PubMed ID: 15936803
[TBL] [Abstract][Full Text] [Related]
37. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes.
Tallini G; Vanni R; Manfioletti G; Kazmierczak B; Faa G; Pauwels P; Bullerdiek J; Giancotti V; Van Den Berghe H; Dal Cin P
Lab Invest; 2000 Mar; 80(3):359-69. PubMed ID: 10744071
[TBL] [Abstract][Full Text] [Related]
38. Four cytogenetic subgroups can be identified in endometrial polyps.
Dal Cin P; Vanni R; Marras S; Moerman P; Kools P; Andria M; Valdes E; Deprest J; Van de Ven W; Van den Berghe H
Cancer Res; 1995 Apr; 55(7):1565-8. PubMed ID: 7882366
[TBL] [Abstract][Full Text] [Related]
39. Synchronous metastasis from lobular carcinoma and primary carcinoma of the endometrium in a patient after tamoxifen therapy.
Vicioso L; Ortega MV; Cívico V; López-Beltrán A
Int J Gynecol Pathol; 2013 Jan; 32(1):66-70. PubMed ID: 23202785
[TBL] [Abstract][Full Text] [Related]
40. Uterine neoplasms in patients treated with tamoxifen.
Silva EG; Tornos C; Malpica A; Mitchell MF
J Cell Biochem Suppl; 1995; 23():179-83. PubMed ID: 8747394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
